Recent Trends in the Initial Therapy for Newly Diagnosed Prostate Cancer in Japan
Recent Trends in the Initial Therapy for Newly Diagnosed Prostate Cancer in Japan
复制标题
DOI：
10.1093/jjco/hyu104
复制
发表时间：
2014-10-01
影响因子：
2.4
通讯作者：
Akaza, Hideyuki
中科院分区：
文献类型：
--
作者：
Onozawa, Mizuki;Hinotsu, Shiro;Akaza, Hideyuki
目的：本研究的目的是调查的趋势随着时间的推移，在最初的治疗前列腺癌在日本。方法：共8291例新诊断的前列腺癌患者的治疗开始于2010年在日本全国范围内进行的多机构观察性研究登记的日本前列腺癌研究组。每个病人的背景特征和初始治疗recorded.Results：诊断时的中位年龄为71岁。T1c型占40.5%，M1型占10.4%。前列腺特异性抗原水平为
Objective: The objective of the present study was to investigate the trends over time in the initial treatment of prostate cancer in Japan.Methods: A total of 8291 patients with newly diagnosed prostate cancer whose treatment started in 2010 were registered in a multi-institutional observational study undertaken nationwide across Japan by the Japan Prostate Cancer Study Group. Each patient's background characteristics and initial treatment were recorded.Results: The median age at diagnosis was 71 years. The proportion of T1c disease was 40.5% and that of M1 disease was 10.4%. The prostate-specific antigen level was